# José Luis Perez‐Gracia

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jose-luis-perez-gracia/

## Facts

| Field | Value |
| --- | --- |
| Citations | 29,916 |
| Field | Cancer Immunotherapy and Biomarkers |
| h-index | 64 |
| i10-index | 156 |
| Last Known Institution | Clinica Universidad de Navarra |
| OpenAlex ID | https://openalex.org/A5044557306 |
| ORCID iD | https://orcid.org/0000-0003-4941-9075 |
| Works | 480 |

## Researcher papers

- [Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial](https://scholariq.org/papers/pembrolizumab-versus-docetaxel-for-previously-treated-pd-l1-positive-advanced/)
- [Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial](https://scholariq.org/papers/atezolizumab-in-patients-with-locally-advanced-and-metastatic-urothelial/)

## Researcher topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Bladder and Urothelial Cancer Treatments](https://scholariq.org/topics/bladder-and-urothelial-cancer-treatments/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)

## Researcher university

- [Clinica Universidad de Navarra](https://scholariq.org/institutions/clinica-universidad-de-navarra/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
